Ibolex

Dexibuprofen, the active ingredient in Ibolex, is a non‑steroidal anti‑inflammatory drug presented as an oral dosage form for oral use. It provides analgesic and anti‑inflammatory effects for adults experiencing mild to moderate pain and inflammation. GNH USA supplies Ibolex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Dexibuprofen is used to manage conditions involving pain and inflammation within the musculoskeletal and dental pathways.

- Acute musculoskeletal pain: reduces pain intensity and improves functional ability. - Inflammatory arthritis: diminishes joint swelling and stiffness. - Dental postoperative pain: alleviates discomfort after dental procedures.

Dexibuprofen may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dyspepsia: indigestion or heartburn. - Abdominal pain: discomfort in the stomach area. - Headache: transient head pain. - Dizziness: feeling light‑headed. - Rash: mild skin irritation.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening. - Severe liver injury: jaundice or elevated enzymes. - Stevens‑Johnson syndrome: severe skin reaction. - Anaphylaxis: acute allergic response. - Renal impairment: reduced kidney function. - Cardiovascular events: increased risk of heart attack or stroke.

Before initiating therapy with Dexibuprofen, consider the following safety measures.

- Assess gastrointestinal risk: avoid in patients with active ulcer disease or a history of GI bleeding. - Evaluate cardiovascular status: use cautiously in individuals with heart disease or hypertension. - Check renal function: adjust or monitor in patients with impaired kidney function. - Review concomitant anticoagulant use: increased bleeding risk when combined with warfarin or similar agents. - Store at ambient temperature: keep in the original pack, protect from moisture.

Dexibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of bleeding. - Other NSAIDs: additive gastrointestinal toxicity. - Corticosteroids: increased ulcer risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors: possible reduction in renal function. - Diuretics: potential for renal impairment when combined.